Home >About Us>Overview

Overview

Pasteurians fighting disease with integrity for all mankind

Missions and Strategy

Institut Pasteur Korea (IPK) is an international research institute focused on addressing global health issues with a combination of cutting edge approaches in order to understand disease mechanisms and develop new treatments. By promoting multi-disciplinary projects, IPK is at the forefront of drug discovery and contributes to Korea’s future scientific resources through research, education and technological innovation.

The institute was established in April 2004 in collaboration with Institut Pasteur Paris and the Korea Institute of Science and Technology (KIST), with support from the Ministry of Science and ICT (MSIT). IPK is also supported by the Gyeonggi Provincial government.

IPK is a private, non-profit foundation of Rep. of Korea with four core missions of public interest – Research, Education, Public Health, and Translation of biomedical discoveries to improve health via technology transfer and industrial partnerships.

RESEARCH

IPK is a growth engine for Korea’s biomedical research industry, working successfully with biotech to develop multi-disciplinary R&D and translate fundamental discovery-based research to enhance public health.

In keeping with Louis Pasteur’s belief, “There are sciences and the applications of science, bound together as the fruit of the tree which bears it”, IPK combines front line biology, IT, and chemistry, with innovative cell-based drug discovery platforms that identify novel molecular targets for potential new therapies to treat diseases. With world-class drug discovery capabilities and a talented team drawn from all over the world, IPK scientists aim to uncover various physiological and pathological processes to devise new strategies for diagnosing, preventing and treating disease. IPK currently focuses on global infectious diseases that represent today’s health challenges such as zoonotic virus infections, viral immunity, tuberculosis, antibiotic resistance, hepatitis, cancer, dengue and neglected diseases, as well as preparing for emerging diseases that may impact future health needs.

IPK is committed to contributing to Korea’s scientific intellectual and technical resources by establishing relevant domestic partnerships with research institutions, academia and industry. IPK recognizes the important role universities and biotech companies’ play in the research and development of novel drugs and that the future of drug development hinges on the innovative and cooperative efforts of public and private organizations.

To date, IPK consists of approximately 100 experts working in discovery biology, core technology platforms, biosafety and so forth.

Find out more about IPK’s success story and our Inventions & Technologies

EDUCATION

Education and teaching are an important part of Louis Pasteur’s legacy and the establishment of IPK. The institute contributes to Korea’s knowledge economy, fanning the spirit of discovery and innovation by nurturing the development of the next generation of scientists and health professionals.

IPK is committed to sharing scientific expertise and technologies with early career researchers and scientists. IPK provides a variety of educational and training opportunities throughout the year, such as internships for undergraduate and graduate students, international practical courses for select scientists with support from the Institut Pasteur International Network, and a Doctoral program (UST-IPK Campus).

At the community level, IPK’s educational programs spark an interest in science and seeds the importance of research in middle and high school students by offering Life Science Classes, opening IPK to school field trips and mentoring science club students.

Learn more about IPK’s Educational Programs and find a program that fits your needs.

PUBLIC HEALTH

IPK is a member of the Institut Pasteur International Network (IPIN) and is actively involved in research on global infectious diseases. IPK stands ready to work in collaboration with national and international health authorities such as the Korea Disease Control and Prevention Agency (KDCA) and the World Health Organization (WHO), providing expertise in infectious diseases to uncover the basic biology of disease and discover effective countermeasures.

In addition, IPK is contributing to national and global efforts to respond to the pandemic of infectious diseases. To respond to the COVID-19 pandemic that has severely affected the entire world since 2020, IPK pioneered drug repositioning research and identified the COVID-19 drug candidates with excellent efficacy. Domestic and overseas clinical trials for the identified drugs are currently undergoing in collaboration with domestic pharmaceutical companies. Earlier in 2015, when an outbreak of MERS occurred in Korea, IPK brought its expertise in infectious diseases to discover effective countermeasures against the causative virus.

INTERNATIONAL

Present on 5 continents, through 33 institutes, the Institut Pasteur International Network (IPIN) plays a major role in research, education and public health via numerous cooperation and training programs and provides a front-line response against emerging, re-emerging and endemic infectious diseases.

As a hub institution, IPK plays a key role in the Network leading drug discovery research and serves as a bridge between Korea and global bio-pharma science. For over a decade, IPK has forged successful partnerships and expanded Korea’s R&D base collaborative research projects with global alliances.

Since 2007, IPK has worked in association with the Drugs for Neglected Diseases initiative (DNDi), a collaborative, and patients’ needs-driven, non-profit organization to develop new treatments for neglected diseases, and has received award recognition multiple times throughout the years for excellence in research and commitment to global health.

IPK also promotes scientific exchanges through internships, international seminars and conferences.

FUNDING

As a private, non-profit organization, IPK relies on funding and support from a number of sources including the Korean government, including the Ministry of Science and ICT (MSIT), national and international grants and projects, profits from providing screening service as well as donations from private citizens.

With your generous donation, together, we can make a difference in the lives of millions of people suffering from a wide range of infectious diseases, today and in the future.

Find out how you can contribute to Institut Pasteur Korea Discovery Fund.